Mixed Messaging: Tier 2 Abuse-Deterrent Opioid Claim Illusive
FDA’s description of Purdue’s Targiniq abuse-deterrent mechanism seems to match up with a Tier 2 claim that the company didn’t receive, but the agency says this isn’t confusing.
FDA’s description of Purdue’s Targiniq abuse-deterrent mechanism seems to match up with a Tier 2 claim that the company didn’t receive, but the agency says this isn’t confusing.